Monday, December 23, 2024
HomeTagsLitain Yeh

Litain Yeh

Arthrosi Completes AR882 Phase 2B Study Enrollment

Arthrosi Therapeutics, Inc., a clinical-stage biotechnology company, announced the completion of enrollment for its global Phase 2b clinical study of AR882 for the treatment...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics